IBDEI0EJ ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6633,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,6634,0)
 ;;=284.2^^31^412^105
 ;;^UTILITY(U,$J,358.3,6634,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6634,1,4,0)
 ;;=4^284.2
 ;;^UTILITY(U,$J,358.3,6634,1,5,0)
 ;;=5^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,6634,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,6635,0)
 ;;=202.40^^31^412^73
 ;;^UTILITY(U,$J,358.3,6635,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6635,1,4,0)
 ;;=4^202.40
 ;;^UTILITY(U,$J,358.3,6635,1,5,0)
 ;;=5^Hairy Cell Leukemia,Unspecified site
 ;;^UTILITY(U,$J,358.3,6635,2)
 ;;=^69587
 ;;^UTILITY(U,$J,358.3,6636,0)
 ;;=287.49^^31^412^115
 ;;^UTILITY(U,$J,358.3,6636,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6636,1,4,0)
 ;;=4^287.49
 ;;^UTILITY(U,$J,358.3,6636,1,5,0)
 ;;=5^Thrombocytopenia,Drug Induced
 ;;^UTILITY(U,$J,358.3,6636,2)
 ;;=^339610
 ;;^UTILITY(U,$J,358.3,6637,0)
 ;;=285.9^^31^412^8
 ;;^UTILITY(U,$J,358.3,6637,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6637,1,4,0)
 ;;=4^285.9
 ;;^UTILITY(U,$J,358.3,6637,1,5,0)
 ;;=5^Anemia NOS
 ;;^UTILITY(U,$J,358.3,6637,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,6638,0)
 ;;=287.9^^31^412^11
 ;;^UTILITY(U,$J,358.3,6638,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6638,1,4,0)
 ;;=4^287.9
 ;;^UTILITY(U,$J,358.3,6638,1,5,0)
 ;;=5^Bleeding Disorder NOS
 ;;^UTILITY(U,$J,358.3,6638,2)
 ;;=^123920
 ;;^UTILITY(U,$J,358.3,6639,0)
 ;;=286.9^^31^412^51
 ;;^UTILITY(U,$J,358.3,6639,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6639,1,4,0)
 ;;=4^286.9
 ;;^UTILITY(U,$J,358.3,6639,1,5,0)
 ;;=5^Coagulation Defect NOS
 ;;^UTILITY(U,$J,358.3,6639,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,6640,0)
 ;;=281.9^^31^412^53
 ;;^UTILITY(U,$J,358.3,6640,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6640,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,6640,1,5,0)
 ;;=5^Deficiency Anemia NOS
 ;;^UTILITY(U,$J,358.3,6640,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,6641,0)
 ;;=280.9^^31^412^84
 ;;^UTILITY(U,$J,358.3,6641,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6641,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,6641,1,5,0)
 ;;=5^Iron Deficiency Anemia NOS
 ;;^UTILITY(U,$J,358.3,6641,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,6642,0)
 ;;=287.5^^31^412^114
 ;;^UTILITY(U,$J,358.3,6642,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6642,1,4,0)
 ;;=4^287.5
 ;;^UTILITY(U,$J,358.3,6642,1,5,0)
 ;;=5^Thrombocytopenia NOS
 ;;^UTILITY(U,$J,358.3,6642,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,6643,0)
 ;;=289.9^^31^412^116
 ;;^UTILITY(U,$J,358.3,6643,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6643,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,6643,1,5,0)
 ;;=5^Thrombocytosis NOS
 ;;^UTILITY(U,$J,358.3,6643,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,6644,0)
 ;;=195.0^^31^412^31
 ;;^UTILITY(U,$J,358.3,6644,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6644,1,4,0)
 ;;=4^195.0
 ;;^UTILITY(U,$J,358.3,6644,1,5,0)
 ;;=5^Ca Head/Face/Neck
 ;;^UTILITY(U,$J,358.3,6644,2)
 ;;=^267306
 ;;^UTILITY(U,$J,358.3,6645,0)
 ;;=202.80^^31^412^88
 ;;^UTILITY(U,$J,358.3,6645,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6645,1,4,0)
 ;;=4^202.80
 ;;^UTILITY(U,$J,358.3,6645,1,5,0)
 ;;=5^Lymphoma NEC Unsp Site
 ;;^UTILITY(U,$J,358.3,6645,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,6646,0)
 ;;=193.^^31^412^49
 ;;^UTILITY(U,$J,358.3,6646,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6646,1,4,0)
 ;;=4^193.
 ;;^UTILITY(U,$J,358.3,6646,1,5,0)
 ;;=5^Ca Thyroid
 ;;^UTILITY(U,$J,358.3,6646,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,6647,0)
 ;;=180.9^^31^412^27
 ;;^UTILITY(U,$J,358.3,6647,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6647,1,4,0)
 ;;=4^180.9
 ;;^UTILITY(U,$J,358.3,6647,1,5,0)
 ;;=5^Ca Cervix
 ;;^UTILITY(U,$J,358.3,6647,2)
 ;;=^267214
 ;;
 ;;$END ROU IBDEI0EJ
